To further explore the molecular pathway involved in BCL-XL-mediated tumor aggressiveness, we next focused our attention on HIF-1/VEGF axis, a key pathway involved in melanoma and glioblastoma vascularization and aggressiveness31,36–40. Here, HIF1A is linked to glioblastoma.